hepatitis C

Bristol-Myers: hepatitis C drug trial hit by safety issue

Bristol-Myers: hepatitis C drug trial hit by safety issue

Reuters

Forget the Numbers, This Pipeline Is King

Forget the Numbers, This Pipeline Is King

Motley Fool

Gilead Begins Single Pill Hepatitis C Study For 2014 Approval

Gilead Begins Single Pill Hepatitis C Study For 2014 Approval

Bloomberg

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection

Yahoo

3 Things to Watch With Gilead Sciences

3 Things to Watch With Gilead Sciences

Motley Fool

Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications

Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications

Forbes

Bristol Hep C Trial Change Has Big Implications

Bristol Hep C Trial Change Has Big Implications

Pharmalot

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug

Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug

Seeking Alpha

Bristol CEO says Gilead holding out on hep C tie-up

Bristol CEO says Gilead holding out on hep C tie-up

Fierce Biotech

Achillion jumps on hepatitis C study

Achillion jumps on hepatitis C study

Marketwatch